A prospective observational study to assess PD-L1 expression in small biopsy samples for non-small-cell lung cancer

A prospective observational study to assess PD-L1 expression in small biopsy samples for non-small-cell lung cancer

Abstract Background Programmed cell death-1 (PD-1) immune checkpoint inhibitor antibody has proven to be effective in advanced non-small cell lung cancer (NSCLC) patients positive for programmed cell death-1 ligand-1 (PD-L1). However, there are currently no prospective studies evaluating PD-L1 expre...

Full description

Bibliographic Details
Main Authors: Akihito Tsunoda, Kei Morikawa, Takeo Inoue, Teruomi Miyazawa, Masahiro Hoshikawa, Masayuki Takagi, Masamichi Mineshita
Format: Article
Language:English
Published: BMC 2019-06-01
Series:BMC Cancer
Subjects:
Lung cancer
Bronchoscopy
Pathology
Immunohistochemistry
Online Access:http://link.springer.com/article/10.1186/s12885-019-5773-3

Internet

http://link.springer.com/article/10.1186/s12885-019-5773-3

Similar Items